BCC tagged posts

An example of a small, superficial BCC lesion that might be treated with imiquimod. Credit: Journal of Investigative Dermatology

Basal cell carcinoma (BCC) is the most common form of human cancer. With a growing aging population, BCC rates are climbing at an alarming rate, with reported cases rising by as much as 10% per year. A new study examines the effectiveness of imiquimod, a topical skin cream used to treat low-risk BCC lesions, over a five-year period. Imiquimod success rates were sustained for the extended study period and did not promote lesion reoccurrence.

Currently, the gold standard of treatment for BCC is excisional or Mohs surgery, both of which require a dermatologist or plastic surgeon...

The green-labelled cells show a basal cell carcinoma in mouse tail epidermis derived from a single mutant stem cell and expanding out of the normal epidermis stained in red. Credit: Adriana Sánchez-Danés

Scientists have identified for the first time the ‘cell of origin’ – in ie the first cell from which the cancer grows – in basal cell carcinoma, the most common form of skin cancer, and followed the chain of events that lead to the growth of these invasive tumours. Our skin is kept healthy by a constant turnover. The process is maintained by ‘progenitor’ cells – the progeny of stem cells – that divide and ‘differentiate’ into fully-functional skin cells to replenish dying skin...